Does OLAPARIB Cause Haematocrit decreased? 40 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Haematocrit decreased have been filed in association with OLAPARIB (Lynparza). This represents 0.2% of all adverse event reports for OLAPARIB.
40
Reports of Haematocrit decreased with OLAPARIB
0.2%
of all OLAPARIB reports
1
Deaths
5
Hospitalizations
How Dangerous Is Haematocrit decreased From OLAPARIB?
Of the 40 reports, 1 (2.5%) resulted in death, 5 (12.5%) required hospitalization, and 1 (2.5%) were considered life-threatening.
Is Haematocrit decreased Listed in the Official Label?
Yes, Haematocrit decreased is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Haematocrit decreased?
CLOZAPINE (1,027)
RUXOLITINIB (562)
ECULIZUMAB (466)
ADALIMUMAB (455)
NIRAPARIB (406)
METHOTREXATE (396)
PALBOCICLIB (357)
RITUXIMAB (328)
ALEMTUZUMAB (283)
PREDNISONE (283)
Which OLAPARIB Alternatives Have Lower Haematocrit decreased Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL